Isofol Medical AB (publ) (STO:ISOFOL)
Sweden · Delayed Price · Currency is SEK 0.6740
+0.0040 (0.60%)
Apr 30, 2026, 12:51 PM CET
Isofol Medical AB Market Cap
Isofol Medical AB has a market cap or net worth of 214.73 million as of April 30, 2026. Its market cap has decreased by -26.14% in one year.
Market Cap
214.73M
Enterprise Value
87.74M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.67
Market Cap Chart
Since April 4, 2017, Isofol Medical AB's market cap has decreased from 853.32M to 214.73M, a decrease of -74.84%. That is a compound annual growth rate of -14.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 214.73M | 4.78% |
| Dec 30, 2025 | 204.93M | -42.85% |
| Dec 30, 2024 | 358.56M | 204.11% |
| Dec 29, 2023 | 117.91M | -1.35% |
| Dec 30, 2022 | 119.52M | -91.99% |
| Dec 30, 2021 | 1.49B | -36.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sprint Bioscience AB | 331.32M |
| Bio-Works Technologies AB | 310.20M |
| Mendus AB | 306.13M |
| Initiator Pharma | 221.79M |
| Xintela AB | 212.73M |
| Xbrane Biopharma AB | 205.64M |
| Active Biotech AB | 165.81M |
| AlzeCure Pharma AB | 158.58M |